We remain at the cutting-edge of scientific research into respiratory medicine, investing more than any other company and working in collaboration with patients and the scientific community to offer innovative medicines aimed at helping to treat patients’ symptoms and reduce the risk of their disease worsening.
For example, by incorporating patient and physician feedback we have ensured our innovative new inhaler is not only effective but also easy to use. We have the broadest portfolio of once-daily medicines in a single inhaler type, which is the result of decades of development. We’re also exploring how the growing ‘internet of things’ can help us to bring smart sensor technology into our respiratory research, medicines and devices.
Innovating to fight respiratory diseases
329 million people suffer from COPD worldwide. A further 358 million suffer from asthma. We are on a journey to help everyone breathe better and live the life they want.
You may also like
Overcoming the challenges of COPD to fulfil a lifelong dream
Joan an 85 year old COPD patient recently achieved her lifelong dream to climb the Great Wall of China. Her daughter Helen tells us Joan’s story.
Severe asthma: when nature’s natural defences work against us
Around 36 million people around the world are living with severe asthma. But, hope could be on the horizon thanks to a better understanding of how certain blood cells malfunction.